UL Solutions Inc.

UL Solutions (NYSE: ULS) is a global safety science company headquartered in Northbrook, Illinois. Founded in 1894 by William Henry Merrill as the Underwriters' Electrical Bureau, the company was known for over a century as Underwriters Laboratories before rebranding to UL Solutions in 2022.

The company provides testing, inspection, certification, training, advisory, and risk management services plus software solutions. UL Solutions operates in over 110 countries with approximately 15,000 employees. The company went public via IPO in April 2024, raising approximately $946 million at a valuation of approximately $7 billion.

For life sciences and pharmaceutical industries, UL Solutions offers ComplianceWire, a learning management system (LMS) used by FDA-regulated industries since 1999. The platform has recorded over 600 million training completions and serves more than 600 customers with 3.6 million users across 153 countries.

ComplianceWire is the LMS of record for FDA-regulated industries since 1999. Under a Cooperative Research and Development Agreement (CRADA) with the FDA, UL Solutions co-developed training courses used by the FDA to train more than 70,000 global, federal, state, and local investigators.

The FDA chose ComplianceWire to power ORA-U, the FDA's Office of Regulatory Affairs virtual university for training investigators and inspectors. Over 150 courses were developed in direct collaboration with the FDA, many authored or reviewed by FDA personnel.

Global regulatory authorities using ComplianceWire include US FDA, China NMPA, Gujarat FDCA (India), and Saudi FDA. The platform serves pharmaceutical, medical device, and biologics companies with over 1,000 e-learning courses including 21 CFR Part 820, CAPA, and GxP compliance content.

ComplianceWire has recorded over 600 million training completions with more than 600 customers and 3.6 million users in 153 countries.

UL Solutions (NYSE: ULS) went public in April 2024 with an upsized IPO of 33.8 million shares at $28 per share, raising approximately $946 million. The IPO valued the company at approximately $7 billion. Shares jumped approximately 25% on the first trading day.

2024 annual revenue was $2.87 billion with 7.17% year-over-year growth. Q3 2025 revenue was $783 million. 2024 earnings were $326 million, an increase of 25.38% from the prior year.

The company projects mid-single digit constant currency organic revenue growth for 2025 with continued Adjusted EBITDA margin improvement.

UL Solutions offers a broad portfolio of safety science services and software. Key offerings for life sciences:

**ComplianceWire LMS**: FDA 21 CFR Part 11 and EU Annex 11 validated learning management system for life sciences. Features GxP training, qualification tracking, compliance dashboards, audit-ready reporting, and supplier/clinical qualification extensions.

**ULTRUS Software Suite**: Integrated platform bringing together UL Solutions' software offerings for regulatory, supply chain, and sustainability management. ComplianceWire is now part of ULTRUS.

**e-Learning Library**: Over 1,000 regulatory courses including 400+ life sciences courses. Many courses co-developed with FDA for inspector training. Content covers 21 CFR Part 820, CAPA, GMP, and compliance training.

**Testing, Inspection & Certification**: Core business includes product safety testing, certification marks, and compliance services across multiple industries.

UL Solutions maintains a unique Cooperative Research and Development Agreement (CRADA) with the US FDA for training content development. The FDA uses ComplianceWire to power ORA-U, their investigator training university.

In June 2024, UL Solutions announced a partnership with ScienceMedia to integrate SMi Source clinical and therapeutic area training solutions into ComplianceWire.

Global regulatory partnerships include China NMPA, Gujarat FDCA (India), and Saudi FDA, all using ComplianceWire for training their regulatory personnel.

ComplianceWire is regularly audited by customers with approximately 50 audits conducted annually through paper, remote, and onsite methods. The platform supports response to regulatory inquiries and internal audits.

UL Solutions provides consulting services for FDA compliance readiness, helping pharmaceutical and medical device companies prepare for inspections. ComplianceWire experts assist with training program design and regulatory compliance preparation.

The platform includes built-in regulatory reports for audit readiness and compliance demonstration.

UL Solutions traces its origins to 1894 and the founding of Underwriters Laboratories by William Henry Merrill. Its UL Mark is a product-safety certification credential carried across its testing and certification business.

UL Solutions describes ComplianceWire as "the gold standard LMS for the life sciences industry", citing its unique FDA partnership through the CRADA programme. The platform has been used by life sciences companies since 1999, recording over 600 million training completions.

UL Solutions has been publicly traded on the NYSE since its April 2024 IPO.

UL Solutions is publicly traded (NYSE: ULS), publishing quarterly earnings reports and investor relations materials alongside sustainability reports and thought leadership content.

ComplianceWire maintains dedicated product pages with resources for pharmaceutical, medical device, and life sciences companies, including FDA observation solutions, GxP training guides, and LMS essentials documentation.

The 2024 IPO drew coverage in financial and industry publications. Recent news includes the ScienceMedia partnership announcement and ComplianceWire feature enhancements for life sciences.